Profile
Coparion is a venture capital firm based in Cologne, Germany, founded in 2016. The firm is led by a team with over 30 years of experience in venture capital and company building, including key figures like David Zimmer and Christian Schulte. Coparion is known for its pragmatic approach and long-term investment strategy, focusing on supporting young technology companies without intervening in their daily operations.
Coparion primarily invests in early-stage technology companies across Germany, with a focus on sectors such as enterprise applications, high tech, and life sciences. The firm manages a fund size of EUR 275 million and typically co-invests with private investors who share similar values and quality standards. Coparion's investment stages include Seed and Series A rounds.
Notable companies in Coparion's portfolio include Tacalyx - drug discovery, koppla - business productivity software, FundaMental Pharma - drug discovery, Protembis - surgical devices, and Tubulis - drug discovery. The firm has been involved in 98 investments and has seen 24 successful exits.
Industry
Coparion Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Fund I
|
Venture Capital (VC)
|
Financial Services
Fintech
Healthcare Services
Marketing and Advertising
Real Estate
SaaS
Security
Software
Transportation
HealthTech
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$225 M
|
March 2016
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.